Image 4_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.tif

Image 4_RBM15-mediated metabolic reprogramming boosts immune response in colorectal cancer.tif

Introduction<p>Immune checkpoint blockade (ICB) therapy has shown promise in treating advanced colorectal cancer, particularly in patients with microsatellite instability-high (MSI-H) tumors. However, only a subset of these patients responds favorably, highlighting the need for strategies to i...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Chen Wang (88408) (author)
مؤلفون آخرون: Mengyan Chen (4330099) (author), Panyu Chen (816216) (author), Jinlu Han (14324619) (author), Hong Hu (62885) (author), Jiong Chen (71072) (author), Qiong Wu (84327) (author), De Zhao (2688874) (author), Tongshuai Wang (1657390) (author), Jingyi Zhou (3681790) (author), Qi Li (67548) (author), Runkai Zhou (20326855) (author), Yugang Wen (3764611) (author), Jing Yang (13969) (author), Min Shi (141075) (author), Yugang Wang (317500) (author)
منشور في: 2025
الموضوعات:
Genetic Immunology
colorectal cancer
RBM15
microenvironment
RNA modification
m6A
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة

مواد مشابهة